Literature DB >> 3566256

Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2'-nor-cyclic GMP on adenovirus replication in vitro.

M Baba, S Mori, S Shigeta, E De Clercq.   

Abstract

The inhibitory effects of 20 selected antiviral compounds on the replication of adenoviruses (types 1 to 8) in vitro were investigated. While 18 compounds were ineffective, 2 compounds, namely (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine [(S)-HPMPA] and 9-[(2-hydroxy-1,3,2-dioxaphosphorinan-5-yl)oxymethyl]guanine P-oxide (2'-nor-cyclic GMP), were highly effective against all adenovirus types assayed in human embryonic fibroblast cultures. Their 50% inhibitory doses were 1.1 microgram/ml for (S)-HPMPA and 4.1 micrograms/ml for 2'-nor-cyclic GMP. They were nontoxic for the host cells at the effective antiviral doses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3566256      PMCID: PMC174721          DOI: 10.1128/AAC.31.2.337

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  (S)-9-(2,3-Dihydroxypropyl)adenine: An Aliphatic Nucleoside Analog with Broad-Spectrum Antiviral Activity.

Authors:  E DE Clercq; J Descamps; P DE Somer; A Holyacute
Journal:  Science       Date:  1978-05-05       Impact factor: 47.728

2.  2'-Nor-cGMP: a seco-cyclic nucleotide with powerful anti-DNA-viral activity.

Authors:  R L Tolman; A K Field; J D Karkas; A F Wagner; J Germershausen; C Crumpacker; E M Scolnick
Journal:  Biochem Biophys Res Commun       Date:  1985-05-16       Impact factor: 3.575

3.  Antiviral, antimetabolic and antineoplastic activities of 2'- or 3'-amino or -azido-substituted deoxyribonucleosides.

Authors:  E De Clercq; J Balzarini; J Descamps; F Eckstein
Journal:  Biochem Pharmacol       Date:  1980-06-15       Impact factor: 5.858

4.  Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.

Authors:  R W Sidwell; J H Huffman; G P Khare; L B Allen; J T Witkowski; R K Robins
Journal:  Science       Date:  1972-08-25       Impact factor: 47.728

5.  Antiviral activity of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic acid.

Authors:  L B Allen; J H Huffman; P Dan Cook; R B Meyer; R K Robins; R W Sidwell
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

Review 6.  Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogs.

Authors:  E De Clercq; R T Walker
Journal:  Pharmacol Ther       Date:  1984       Impact factor: 12.310

7.  Adenovirus infection in the immunocompromised patient.

Authors:  J M Zahradnik; M J Spencer; D D Porter
Journal:  Am J Med       Date:  1980-05       Impact factor: 4.965

8.  New human adenovirus (candidate adenovirus type 35) causing fatal disseminated infection in a renal transplant recipient.

Authors:  H Stalder; J C Hierholzer; M N Oxman
Journal:  J Clin Microbiol       Date:  1977-09       Impact factor: 5.948

9.  Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus.

Authors:  S Shigeta; T Yokota; T Iwabuchi; M Baba; K Konno; M Ogata; E De Clercq
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

Review 10.  Antiviral effects of phosphonoformate (PFA, foscarnet sodium).

Authors:  B Oberg
Journal:  Pharmacol Ther       Date:  1982       Impact factor: 12.310

View more
  14 in total

1.  Antiadenovirus activities of several classes of nucleoside and nucleotide analogues.

Authors:  L Naesens; L Lenaerts; G Andrei; R Snoeck; D Van Beers; Antonin Holy; Jan Balzarini; Erik De Clercq
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

2.  Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus.

Authors:  M Baba; R Snoeck; R Pauwels; E de Clercq
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

3.  Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo.

Authors:  E De Clercq; A Holý; I Rosenberg
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

4.  Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice.

Authors:  E De Clercq; A Holý
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

5.  Small-molecule screening using a whole-cell viral replication reporter gene assay identifies 2-{[2-(benzoylamino)benzoyl]amino}-benzoic acid as a novel antiadenoviral compound.

Authors:  Emma K Andersson; Mårten Strand; Karin Edlund; Kristina Lindman; Per-Anders Enquist; Sara Spjut; Annika Allard; Mikael Elofsson; Ya-Fang Mei; Göran Wadell
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

6.  Mechanism of inhibition of adenovirus DNA replication by the acyclic nucleoside triphosphate analogue (S)-HPMPApp: influence of the adenovirus DNA binding protein.

Authors:  Y M Mul; R T van Miltenburg; E De Clercq; P C van der Vliet
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

7.  Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents.

Authors:  R Pauwels; J Balzarini; D Schols; M Baba; J Desmyter; I Rosenberg; A Holy; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

8.  Transport of 9-(2-phosphonomethoxyethyl)adenine across plasma membrane of HeLa S3 cells is protein mediated.

Authors:  T Cihlár; I Rosenberg; I Votruba; A Holý
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

9.  Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.

Authors:  J Neyts; H Sobis; R Snoeck; M Vandeputte; E De Clercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-04       Impact factor: 3.267

Review 10.  Adenoviruses in the immunocompromised host.

Authors:  J C Hierholzer
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.